Ejaculation increases the serum prostate-specific antigen concentration

Urology

Volumn 47, Issue 4, 1996, Pages 511-516

  Tchetgen, Marie Blanche ^b   Song, James T ^b   Strawderman, Myla ^b   Jacobsen, Steven J ^b   Oesterling, Joseph E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; EJACULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RISK FACTOR; SEMEN ANALYSIS;

EID: 0029884437     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)80486-5     Document Type: Article

References (24)

1. Wingo PA, Tong TS, and Bolden S: Cancer statistics 1995. CA Cancer J Clin 45: 8-30, 1995.
2. Wang MC, Valenzuela LA, Murphy GP, and Chu TM: Purification of a human prostate-specific antigen. Invest Urol 17: 159-163, 1979.
3. Ercole CJ, Lange PH, Mathisen M, Chiou RK, Reddy PK, and Vessela RL: Prostate-specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer. J Urol 138: 1181-1184, 1987.
4. Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr, Bruzek DJ, Rock RC, Brendler CB, and Walsh PC: Prostate-specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 139: 766-772, 1988.
5. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, and Redwine E: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-916, 1987.
6. Seamonds B, Whittaker B, Yand N, Shaw LM, Anderson K, and Bollinger J: Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers. Urology 28: 472-479, 1986.
7. Oesterling JE, Rice DC, Glenski WJ, and Bergstralh EJ: Effect of cystoscopy, prostate biopsy and transurethral resection of prostate on serum prostate-specific antigen concentration. Urology 42: 276-282, 1993.
8. Yuan JJ, Coplen DE, Petros JA, Figenshau RS, Ratliff TL, Smith D, and Catalona WJ: Effects of rectal examination, prostatic massage, ultrasonography, and needle biopsy on serum prostate-specific antigen levels. J Urol 147: 810-814, 1992.
9. Glenski WJ, Klee GG, Bergstralh EJ, and Oesterling JE: Prostate-specific antigen: establishment of the reference range for the clinically normal prostate gland and the effect of digital rectal examination, ejaculation, and time on serum concentrations. Prostate 21: 99-110, 1992.
10. McAleer JK, Gerson LW, McMahon D, and Geller L: Effect of digital rectal examination (and ejaculation) on serum prostate-specific antigen after 24 hours. Urology 41: 111-112, 1993.
11. Simak R, Madersbacher S, Zhang ZF, and Maier U: The impact of ejaculation on serum prostate-specific antigen. J Urol 150: 895-897, 1993.
12. Wesphal J, Heidenreich A, Zumbe J, and Engelmann U: The impact of ejaculation on serum PSA. J Urol 153: 464A, 1995.
13. Doe RP, and Mellinger GT: Circadian variation of serum acid phosphatase in prostatic cancer. Metabolism 13: 445-452, 1964.
14. Dejter SW Jr, Martin JS, McPherson RA, and Lynch JH: Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation. Urology 32: 288-292, 1988.
15. Schifman RB, Ahman FR, Elvick A, Ahman M, Coulis K, and Brawer MK: Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared. Clin Chem 33: 2086-2088, 1987.
16. Oesterling JE, Chute CG, Jacobsen SJ, Guess HA, Panser CA, Johnson CL, and Lieber MM: Longitudinal changes in serum PSA (PSA velocity) in a community-based cohort of men. J Urol 149(suppl): 412A, 1993.
17. Riehmann M, Rhodes PR, Cook TD, Grose GS, and Bruskewitz RC: Analysis of variations in prostate-specific antigen values. Urology 42: 390-397, 1993.
18. Dnistrian AM, Schwartz MK, Smith CA, Nisselbaum JS, and Fair WR: Abbot IMx evaluated for assay of prostate-specific antigen in serum. Clin Chem 38: 2140-2142, 1992.
19. Stamey TA, Prestigiacomo A, and Komatsu K: Physiological variation of serum prostate-specific antigen (PSA) from a screening population in the range of 4-10 ng/ml using the Hybritech Tandem-R PSA assay. J Urol 153: 420A, 1995.
20. Vessella RL, Noteboom J, and Lange PH: Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen. Clin Chem 38: 2044-2054, 1992.
21. Klee GG, Dodge LA, Zincke H, and Oesterling JE: Measurement of serum prostate-specific antigen using IMx prostate-specific antigen assay. J Urol 151: 94-98, 1994.
22. Oesterling JE, Bilhartz DL, and Tindall DJ: Clinically useful serum markers for adenocarcinoma of the prostate. II. Prostate-specific antigen. Am Urol Assoc Update Ser 10: 137, 1991.
23. Oesterling JE, Jacobsen S, Chute CG, Guess HA, Girman CJ, Panser LA, and Lieber MM: Serum prostate-specific antigen in a community-based population of healthy men. JAMA 270: 860-864, 1993.
24. US Bureau of the Census: Statistical abstract of the United States. Washington, DC: US Government Printing Office, 1993.